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Hesx1 is a highly conserved homeobox gene present in vertebrates, but absent from invertebrates. Gene targeting experiments in mice have shown
that this transcriptional repressor is required for normal forebrain and pituitary development. In humans, mutations in HESX1 impairing either its
repressing activity or DNA binding properties lead to a comparable phenotype to that observed inHesx1 deficient mice. In an attempt to gain insights
into the molecular function of HESX1, we have performed a yeast two-hybrid screen and identified DNAmethyltransferase 1 (DNMT1) as a HESX1
binding protein. We show thatDnmt1 is co-expressed withHesx1within the anterior forebrain and in the developing Rathke's pouch. Mapping of the
interacting regions indicates that the entire HESX1 protein is required to establish binding to a portion of the N-terminus of DNMT1 and its catalytic
domain in the C-terminus. TheHESX1–DNMT1 complexes can be immunoprecipitated in cells and co-localise in the nucleus. These results establish
a link between HESX1 and DNMT1 and suggest a novel mechanism for the repressing properties of HESX1.
© 2007 Elsevier B.V. Open access under CC BY license.Keywords: DNA methylation; Repression; Homeobox; Forebrain; Pituitary; Mouse1. Introduction
Hesx1 is a transcription factor that belongs to the paired class
of homeobox genes. Hesx1 is conserved in vertebrates, but it is
absent from other animal groups, including amphioxus and
ascidians. Hesx1 is expressed in the rostral region of the devel-
oping vertebrate embryo, but expression has not been detected
in any adult tissues or established cell lines, with the exception
of mouse ES cells [1,2]. In mouse, Hesx1 expression is very
dynamic and is regulated by specific enhancers located in the 5′Abbreviations: aa, amino acid; DNMT1, DNA methyltransferase 1; SAFB1,
scaffold attachment factor beta 1; RNF2, ring finger protein 2; Lonp2, lon
peptidase 2, peroxisomal; ZFP592, zinc finger protein 592; BTBD2, BTB (POZ)
domain containing 2; SRFBP1, serum response factor binding protein 1;
ZMIZ1, zinc finger MIZ-type containing 1; SOD, septo-optic dysplasia; TLE1,
transducin-like enhancer of split 1; N-CoR, nuclear co-repressor; eh1, engrailed
homology domain 1; GST, glutathione-S-transferase; Gal4DBD, Gal4 DNA
binding domain; IVT, in vitro translated; HRP, horse radish peroxidase; PFA,
paraformaldehyde; PcP, polycomb group; EZH2, enhancer of zeste homologue;
ES cells, embryonic stem cells
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Open access under CC BY license.and 3′ regions of the locus [3]. Hesx1 transcripts are first
detected in the anterior endoderm of the early gastrula embryo,
but the most prominent sites of expression are the anterior
neural ectoderm, which later gives rise to the forebrain, and
Rathke's pouch, the primordium of the anterior pituitary gland
[1,2]. The expression pattern of Hesx1 orthologues in other
vertebrates is highly conserved [4,5].
Previous research has shown that Hesx1 is essential for
normal forebrain and pituitary gland formation in mammals
[6,7]. Hesx1-deficient mouse embryos show variable degrees of
forebrain defects, including abnormalities in dorsal midline
structures, namely the septum pellucidum, corpus callosum, and
anterior and hippocampal commissures. Hesx1 homozygous
mutants also show pituitary dysplasia, anophthalmia or micro-
phthalmia and defects in the olfactory bulbs. A comparable
phenotype is observed in the congenital human disorder septo-
optic dysplasia (SOD), a syndrome characterised by variable
combinations of pituitary abnormalities, midline forebrain
defects and optic nerve hypoplasia [6]. Indeed, it has been
shown that mutations in human HESX1 are associated with
familial cases of SOD and other forms of hypopituitarism
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growth hormone deficiency (IGHD)] [8–16].
At the molecular level, there is evidence indicating that
HESX1 can function as a transcriptional repressor in vitro and in
vivo [10,11,17]. HESX1 contains two repressor domains, one
located in the N-terminus (eh1 and HRPW motifs) and the other
in the homeodomain (Fig. 1A). The N-terminal repressing do-
main binds TLE1, a mammalian orthologue of Groucho,
whereas the homeodomain interacts with N-CoR [17]. TLE1
and N-CoR are proteins that mediate transcriptional repression
through interactions with DNA binding transcription factors and
histone deacetylases [17]. In Xenopus, the repressing activity of
HESX1 is required for the regulation of both neural differen-
tiation and patterning of the anterior neuroectoderm [18]. Re-
cently, we have shown that the mechanism underlying the
forebrain defects in the Hesx1-deficient embryos involves the
ectopic expression of genes with caudalising activities within the
anterior forebrain of the very early mouse embryo [19]. Normal
pituitary organogenesis also requires the repressor functions of
HESX1 [17]. Therefore, HESX1 is a critical transcriptional
repressor that plays a broad role in the development of the fore-
brain and associated structures, such as the olfactory bulbs, eyes
and pituitary gland.
It seems likely that HESX1 exerts its functions not only
through the interaction with TLE1 and N-CoR, but further
interacting proteins, which remain to be characterised. To search
for novel HESX1-interacting proteins, we have performed a
yeast two-hybrid screen on a 9.5–10.5 dpc (days post coitum)Fig. 1. Diagram of HESX1 and DNMT1 proteins showing their functional domains a
and HRPW) interact with the repressor TLE1, whilst the homeodomain mediates inter
PCNA binding motif; (2) the nuclear localisation signal (NLS); (3) the targeting sequ
2); and (6) the catalytic domain. The regions involved in protein–protein interaction
adapted from Spada et al. [21].cDNA mouse library. We have identified DNMT1, a protein
responsible for CpG methylation and repression of gene expres-
sion, as a HESX1 partner [20–22]. We have mapped the regions
of the proteins involved in the interaction and show that
HESX1–DNMT1 complexes are present in cells and that both
proteins co-localise in the nucleus. We demonstrate, by in situ
hybridisation and RT-PCR, that Dnmt1 is actively transcribed in
Hesx1-expressing cells in the forebrain and in Rathke's pouch
of the developing mouse embryo. In transfected cells, the re-
pressor activity of HESX1, which is mediated by the co-repres-
sors TLE1 and N-CoR, cannot be enhanced by the addition of
DNMT1 in a mammalian one-hybrid system. The link between
HESX1 and DNMT1 suggests that HESX1 might repress tran-
scription by an alternative mechanism, namely through CpG
methylation of HESX1 target genes.
2. Experimental procedures
2.1. Plasmid constructs
Two bait vectors were constructed by fusing either the full-length HESX1 (aa
1–185) protein or the N-terminal half (aa 1–107, excluding the homeodomain),
in frame to the Gal4 DNA binding domain in the pGBDU-C vector [23]. GST–
HESX1 andGST–DNMT1 constructs were generated by cloning specific coding
sequences into the pGEX-4T vector (Roche). Plasmids containing full-length
cDNAs for the interactors were obtained from the IMAGE consortium (MRC
Geneservice, Cambridge). These clones were 5706204 (Dnmt1), 4021046
(Rnf2); 6401542 (Lonp2); 5009612 (Srfbp1); 6413080 (Btb2); 6856060 (Zmiz1).
An IMAGE clone (6826575) lacking 120 aa of the N-terminal part of Zfp592was
also obtained. A full-length Safb1 clone was kindly provided by Dr. Oesterreichnd interacting partners. (A) Two domains in the N-terminal half of HESX1 (eh1
action with the N-CoR. (B) DNMT1 contains multiple domains including (1) the
ence (TS); (4) the CxxC domain; (5) the polybromo domains 1 and 2 (BAH1 and
s with previously reported DNMT1 partners are indicated. This image has been
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cloned into the pCMV/SV40-Flag vector (Stratagene) and sequenced. For the
mammalian one-hybrid systemwe used two reporter vectors: (i) p-Gal4BS-SV40
firefly luciferase reporter vector [10,11,17]; (ii) p-P3-SV40 firefly luciferase
[17,24]. When cells are transfected with these vectors, expression of luciferase is
constitutively active, but it can be repressed by co-transfection of plasmids
expressing either Gal4 DNA binding domain (DBD)–HESX1 fusion protein or
just full-length HESX1, respectively [10,11,17]. The p-Gal4DBD–Hesx1
construct was built by fusing the full-length coding region of the murine
Hesx1 cDNA to sequences expressing the Gal4DBD in the pM mammalian
vector (Clontech). The efficiency of transfectionwas standardised using the pRL-
SV40 renilla luciferase (Promega) as an internal control. Constructs expressing
HA–HESX1, Flag–HESX1 and untagged HESX1 were built by cloning the
murine Hesx1 coding sequence into the HA–pCDNA3 (Invitrogen), pCMV/
SV40-Flag vector (Invitrogen) and pCAβ-Link [25] vectors, respectively. Primer
sequences are available on request.
2.2. Yeast two-hybrid screen
We used a 9.5–10.5 dpc mouse expression library, kindly provided by Dr.
Weintraub (Howard Hughes Medical Institute, USA) and Dr. Scambler (Institute
of Child Health, UK). In this library, cDNAs are fused to a sequence encoding
the activation domain of the herpes simplex virus protein VP16 [26]. Sac-
charomyces cerevisiae PJ69-4A strain cultures were independently transformed
with the two bait plasmids and single clones were assayed for protein expression
by Western blot using a HESX1 antibody [19]. Protein levels were much higher
in yeast clones expressing the Gal4DBD–HESX1 (aa 1–107) than in those
expressing Gal4DBD–HESX1 (aa 1–185) (Sajedi, E. and Martinez-Barbera,
J.P., unpublished data). For the yeast two-hybrid screen, 150 μg of plasmid DNA
from the expression library (equivalent to approximately 1.0×106 molecules)
was transformed into yeast strains expressing either Gal4DBD–HESX1 (aa
1–185) or Gal4DBD–HESX1 (aa 1–107), and plated onto medium lacking
leucine, uracil, histidine, adenine and supplemented with X-alpha-Gal and
3-amino triazol as described [26]. After selection, 200 resistant clones were
chosen for further analysis. Putative interactors were amplified by PCR with
primers flanking the cloning site of the VP16 vector, purified and sequenced.
Primer sequences are available on request. Plasmid DNA was purified from
yeast cultures using the QIAprep Spin Miniprep kit (Qiagen) after an initial step
of lyticase treatment to digest the yeast cell wall.
2.3. GST pull-down experiments
Plasmids expressing GST–HESX1 and GST–DNMT1 sequences were used
to transform the Escherichia coli BL21 strain. Liquid cultures were grown until
OD600 reached a value of 0.6. Induction of protein expressionwas achieved by an
addition of 0.2 mM IPTG and incubation at 37 °C for 3–5 h. Bacteria were
pelleted at 4 °C and resuspended in lysis buffer containing 20 mM Tris–HCl pH
7.5, 200 mM NaCl, 1 mM EDTA, supplemented with protease inhibitor cocktail
(Roche), at a ratio of 10 ml of buffer per liter of culture. After sonication, extracts
were centrifuged at 12,000×g for 30 min at 4 °C, and cleared lysates were
incubated with glutathione–sepharose beads (Roche) following manufacturer's
instructions. After five washes in lysis buffer, GST fusion proteins bound to the
beads were quantified by performing a Bradford assay (Bradford Reagent,
SIGMA), aliquoted and kept at −80 °C in lysis buffer containing 10% glycerol
(binding buffer). In vitro translation was performed using the TNT Quick Couple
Transcription/Translation kit (Promega) and 35S-methionine (Amersham) as
recommended by the manufacturer. Around 2 μg of protein (either GST–
HESX1, GST-interactor or GSTalone) bound to glutathione–sepharose beads was
incubated with the 35S-methionine-labelled interactor or ES cell protein extracts for
2 h at 4 °C in binding buffer. After three washes in lysis buffer, an equal volume of
2× SDS-PAGE sample buffer was added and samples were denatured at 100 °C for
5 min. Proteins eluted from the beads were subjected to SDS-PAGE, Coomassie
stained, dried and exposed to an autoradiographic film.
2.4. Expression analysis in mouse embryos
For RT-PCR, total RNAwas isolated from the anterior region of the neural plate
of 8.5 dpc embryos and the developingRathke's pouch of 12.5 dpcwild-typemouseembryos using the RNeasy Micro Kit (Qiagen). First strand cDNA synthesis was
performed using the Omniscript RT Kit (Qiagen) according to manufac-
turer's recommendations. Amplification of Hesx1, Dnmt1, Safb1, Lonp2, Zfp592,
Srfbp1 and Gapdh (endogenous control) was performed using specific primers.
Primer sequences were Hesx1s, 5′-cccagatcttcccagtgagacttc-3′ and Hesx1as,
5′-gattctgtcttcctctaagtttagc-3′; Dnmt1s, 5′-agttccgtggctacgaggag-3′ and Dnmt1as,
5′-gtctccgtttggcagctggat-3′; Safb1s, 5′-tgcaggagatggaagaggcatc-3′ and Safb1as,
5′-gccgtgctactctgttcaactg-3′; Lonp2s, 5′-atgtcctccgtgagccccatc-3′ and Lon-
p2as, 5′-aactgcagggacggacatatc-3′; Zfp592s, 5′-aagtcctcagcacagagacg-3′ and
Zfp592as, 5′-aagtggcaaggctggaattacag-3′; Srfbp1s, 5′-atggcggctgaccctcttcct-
3′ and Srfbp1as, 5′-cccctggtgttcagtgttaacc-3′; Gapdhs, 5′-ttccagtatgactccact-
cacg-3′ and Gapdhas, 5′-ggatgcagggatgatgttct-3′. In situ hybridisation on whole
embryos and paraffin sections was performed as previously described [17,19].
2.5. Antibodies
For immunoprecipitation, anti-Flag M2 monoclonal (SIGMA) and anti-HA
rat monoclonal antibodies (SIGMA) were used. Immunoblotting was performed
using anti-Flag M2-peroxidase conjugate (SIGMA) and anti-HA peroxidase
conjugate rat monoclonal (Roche). DNMT1 was detected using an anti-DNMT1
rabbit polyclonal antibody (AbCam). For immunofluorescence experiments anti-
Flag rabbit polyclonal (SIGMA) and anti-HA rat monoclonal (SIGMA) primary
antibodies were used and Alexa Fluor 488 goat anti-mouse IgG and Alexa Fluor
594 goat anti-rabbit IgG (Molecular Probes) were used as secondary antibodies.
2.6. Cell culture and transfections
293T and CHO cells were grown in Dulbecco's modified Eagle's medium
(DMEM) (SIGMA), supplemented with 10% fetal calf serum, 2 mM L-gluta-
mine, 100 U/ml penicillin G and 100 μg/ml streptomycin. For immuno-
precipitation experiments, cells were co-transfected with 5 μg of each plasmid at
30–40% confluency using the standard calcium phosphate precipitation protocol
(SIGMA). For immunofluorescence experiments, cells were cultured to 70%
confluency on glass cover slips and transfected using Lipofectamine 2000
(Invitrogen). For the luciferase assays, cells were plated on 12-well tissue culture
plates at a density of 1.25–1.5 105 cells per well, and transfected using Lipofec-
tamine (Invitrogen) the following day. Variable amounts of reporter and effector
vectors were used in these experiments, but the total concentration of DNA used
for transfections was kept constant at 1.0 μg of DNA per well by adding
pBlueScript plasmid (Stratagene). CCE ES cells were grown as described [27].
2.7. Immunoprecipitation and immunoblotting
Cells were harvested 48 h after transfection and resuspended in lysis buffer
containing 1% Triton X-100 for 20 min on ice. Protein extracts were separated
from nuclei by centrifugation at 3000×g for 10 min at 4 °C and quantified by
performing a Bradford assay (Bradford Reagent, SIGMA). Approximately,
0.5–1.0 mg of total protein was incubated with anti-Flag or anti-HA antibodies
bound to protein G sepharose beads for 2 h at 4 °C (Roche). After three washes
in lysis buffer, immunoprecipitates were resolved by SDS-PAGE and transferred
to Immobilon filters (Millipore). Filters were then immunoblotted using HRP-
conjugated anti-Flag or anti-HA antibodies. Immunoreactive proteins were
visualised using the ECL Detection Reagent System (Amersham).
2.8. Indirect immunofluorescence
Two days after transfection, CHO cells were fixed in 4% PFA for 20 min on
ice and washed 3×5 min in PBT (phosphate-buffered saline containing 0.1%
Triton X-100). After blocking in 10% fetal calf serum, cells were incubated with
anti-Flag and anti-HA antibodies at 4 °C overnight. Samples were then washed
4×5 min in PBT and incubated with secondary antibodies for 1 h at room
temperature. After 3×5-min washes in PBT, cells were mounted on slides using
Vectashield with DAPI (Vector Laboratories). Samples were viewed with a Leica
TCS SP Confocal Microscope using an argon–krypton laser and UV10×/0.4 or
40×/0.5 NA dry HC-PLAPO lens (Leica). Images were captured with Leica TCS
NTsoftware, composed of 16 sections and four accumulates and processed using
ImageJ 1.30v (National Institutes of Health).
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3.1. A yeast two-hybrid screen identifies several
HESX1-interacting proteins
We carried out two independent yeast two-hybrid screens
using bait vectors expressing either the full-length HESX1
protein (aa 1–185) or the N-terminal half (aa 1–107) fused to the
Gal4DBD. After selection, surviving clones were isolated and
characterised further. Clones containing sequences in framewith
the VP16 activation domain corresponded to sequences en-
coding nine different proteins (Table 1). Yeast clones encoding
overlapping sequences of the same putative interactors were
repeatedly identified from the two independent screens.
To confirm that the interactors bound to HESX1 sequences,
and did not bind Gal4DBD, or activate the expression of the
selection markers on their own (auto-activation), we purified
plasmids harbouring putative interactor sequences and trans-
formed the PJ69-4A yeast strain and yeast strains expressing
either Gal4DBD–HESX1 (aa 1–185), Gal4DBD–HESX1 (aa
1–107) and Gal4DBD. Seven out of nine putative interactors
(DNMT1, LONP2, SRFBP1, SAFB1, ZFP592, ZMIZ1 and
BTBD2) were able to interact specifically with HESX1 se-
quences. RNF2 and NRBP2 were found to be false positives
(Table 1, Fig. 2 and Sajedi, E. and Martinez-Barbera, J.P., un-
published data).
To validate these interactions further and to investigate
whether they require a direct contact between the proteins, we
carried out GST pull-down experiments using GST–HESX1 (aa
1–185), GST–HESX1 (aa 1–107) and GST alone. Three of the
interactors, DNMT1, LONP2 and SRFBP1, showed a higher
affinity for the GST–HESX1 (aa 1–185) protein when com-
pared with the GST–HESX1 (aa 1–107) (Fig. 3A–C). In con-
trast, SAFB1 exhibited stronger binding to GST–HESX1 (aa 1–Table 1
Results from the yeast two-hybrid screens
HESX1-interacting protein Accession
number
Number
of clones a
Number of
overlapping
clones
Scaffold attachment factor β
1 (SAFB1)
XM_128715 20 3
Serum response factor binding
protein 1 (SRFBP1)
NM_026040 17 4
DNA methyltransferase
1 (DNMT1)
NM_010066 14 3
Ring finger protein 2 (RNF2) NM_011277 6 3
BTB (POZ) domain containing
2 (BTBD2)
BC055704 6 1
Lon peptidase 2, peroxisomal
(LONP2)
BC049090 3 2
Zinc finger protein 592 (ZFP592) BC059073 3 2
Zinc finger, MIZ-type containing
1 (ZMIZ1)
BC058646 3 1
Nuclear receptor binding protein
2 (NRBP2)
BC012437 1 1
a SAFB1, SRFBP1, DNMT1, BTB (POZ), ZFP592 and ZMIZ1 were
identified in both yeast two-hybrid screens. RNF2 was only identified in the
screen using Gal4-DBD-HESX1 (aa 1–107) as bait, whilst LONP2 and NRBP2
were both identified in the screen using Gal4-DBD-HESX1 (aa 1–185) as bait.107) (Fig. 3E). In these experiments, ZFP592 binding to both
GST–HESX1 fusion proteins was indistinguishable (Fig. 3D).
Among the five identified HESX1 interactors, DNMT1,
SAFB1 and SRFBP1 are nuclear proteins that have been pre-
viously characterised [20–22,28,29]. ZFP592 is a Kruppel-like
C2H2-type zinc finger protein of unknown function [30], whilst
LONP2 encodes a Lon peptidase that belongs to the large
family of AAA (ATPases associated with diverse cellular
activities) proteases.
3.2. Expression analysis of the HESX1 partners in
mouse embryos
Whole-mount in situ hybridisation on 8.5 dpc wild-type
embryos was used to investigate whether the identified interactors
were co-expressed with Hesx1 within the anterior forebrain. At
8.5 dpc, Hesx1 is expressed in the ventral region of the anterior
forebrain including the proximal part of the developing optic
stalks (Fig. 4A, B) [1,2]. Dnmt1, Safb1, Srfbp1, Zfp592 and
Lonp2 were all ubiquitously expressed within the neural tube,
including the anterior forebrain (Fig. 4C–L). This expression
analysiswas also performed at 12.5 dpc by in situ hybridisation on
paraffin sections to assess the degree of co-expression between
Hesx1 and the interactors in the developing Rathke's pouch.
Hesx1 shows a characteristic high-dorsal to low-ventral gradient
of expression in Rathke's pouch [1,2,17] (Fig. 4M). Dnmt1 and
Safb1 both showed the same dorso-ventral gradient in Rathke's
pouch, indicating that they are co-expressed withHesx1 (Fig. 4N,
O). Lonp2 showed a weak and homogeneous pattern of ex-
pression in Rathke's pouch, and Srfbp1 and Zfp592 mRNAwas
not detected by slide in situ hybridisation (data not shown).
RT-PCRonRNA samples isolated from the heads (rostral to the
mid-hindbrain boundary) of 8.5 dpc embryos and Rathke's pouch
of 12.5 dpc wild-type embryos was carried out to complement the
in situ hybridisation analysis (Fig. 4P). In heads, Dnmt1, Safb1
and Zfp592 appeared to be expressed at higher levels than Srfbp1
and Lonp2, although we did not perform quantitative PCR. In
Rathke's pouch, expression of Srfbp1 and Zfp592 was barely
detectable, but Dnmt1, Safb1 and Lonp2 mRNA was amplified
abundantly. Together, these expression analyses suggest that
Hesx1 is co-expressed with the identified interactors either within
the anterior forebrain, Rathke's pouch or both.
Protein localisation was not investigated in mouse embryos
because the available anti-HESX1 antibodies (either commer-
cially or our own-produced anti-HESX1 sera) do not work in
immunocytochemistry assays. However, immunofluorescence
on transfected CHO cells using constructs expressing tag-
HESX1 and tag interactors revealed nuclear localisation for
HESX1 and all interactors [19–22,28,29], except for LONP2,
which localises to both the nucleus and the cytoplasm (Sajedi,
E. and Martinez-Barbera, J.P., unpublished data).
We have previously demonstrated that HESX1 is a
transcriptional repressor, able to recruit TLE1 and N-CoR to
artificial promoters to repress transcription [10,11,17]. There is
compelling evidence demonstrating the involvement of
DNMT1 in CpG methylation and control of gene expression
[20–22,31–33]. Therefore, the interaction of HESX1 with
Fig. 3. GST pull-down experiments with DNMT1, LONP2, SRFBP1, Zfp592 and SAFB1. HESX1-interacting proteins were in vitro translated in the presence of
35S-methionine and incubated with 2.0–3.0 μg of either, GST alone, GST–HESX1 (aa 1–185) or GST–HESX1 (aa 1–107). One tenth of the labelled protein used
for the pull-down experiment (arrowheads) was loaded as a control (input). (A–E) Results of GST pull-down experiments with DNMT1 (A), LONP2 (B), SRFBP1
(3), ZFP592 (D) and SAFB1 (E) show specific binding to HESX1 sequences, but only very weakly or not at all to GST. (F) Representative Coomassie stain of the
proteins used in the GST pull-down experiments. Molecular weight markers are indicated on the left of each panel. Predicted molecular weights are: 178 kDa
(DNMT1); 94 kDa (LONP2); 49 kDa (SRFBP1); 121 kDa (ZFP592); 103 kDa (SAFB1).
Fig. 2. HESX1-interacting proteins in yeast. Transformation of PJ69-4A yeast strain (b), and yeast strains expressing either Gal4DBD–HESX1 (aa 1–185)
(a), Gal4DBD–HESX1 (aa 1–107) (d), Gal4DBD alone (c), with plasmids encodingHESX1-interacting proteins fused to VP16 activation domain. Specific interactions
are observed with DNMT1, SRFBP1, LONP2, SAFB1 and ZFP592, as shown by the growth of yeasts transformed only with plasmids containing HESX1 sequences
(a, d). However, RNF2 is a false positive, as it is able to bind Gal4DBD and to activate the expression of the selecting genes in the absence of HESX1 sequences.
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Fig. 4. Expression analyses of the HESX1 partners in the forebrain and Rathke's pouch of wild-type mouse embryos. (A–L) Whole-mount in situ hybridisation on
wild-type mouse embryos. Probes and developmental stages are indicated on the panels. Top row, lateral view, anterior to the left. Bottom row, rostral view. All
interactors are co-expressed with Hesx1. (M–O) In situ hybridisation on sections of Rathke's pouch of 12.5 dpc mouse embryos. Note the high-dorsal to low-ventral
gradient of expression of Hesx1, Dnmt1 and Safb1. (P) RT-PCR from RNA samples purified from mouse pituitaries at 12.5 dpc and mouse heads at 8.5 dpc for Hesx1
and the five interactors. Amplification of the RNA samples prior to retrotranscription (c-) demonstrates the absence of DNA contamination.
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activity through the modification of the target gene expression
patterns. We decided to characterise further the physical
interaction between HESX1 and DNMT1.
3.3. Mapping of the HESX1- and DNMT1-interacting regions
The GST pull-down assay was used to define the interacting
domains on each protein. The use of a series of GST–HESX1
deletion mutant proteins and 35S-Met-labelled IVT (in vitro
translated) full-length DNMT1 revealed the strongest binding
with the full-length HESX1 protein (aa 1–185) (Fig. 5B). Weak
binding was observed with the N-terminal part of HESX1 (aa 1–
107) and no binding was detected with any of the other HESX1
constructs (Fig. 5B). These data suggest that residues distributed
throughout the whole tertiary structure of the HESX1 protein
are likely to be required for a complete interaction. However, the
N-terminal half of HESX1 confers enough binding properties to
form a weak complex in vitro.
GST pull-down assays using 35S-Met-labelled IVT full-
length HESX1 with a series of GST–DNMT1 mutants encom-
passing distinct domains were used to map the regions of
DNMT1 engaged in the interaction. Binding was consistently
observed with peptides containing domains included in the first
748 aa of DNMT1 (Fig. 5E). Numerous functional domains have
been mapped to this part of the protein, such as the PCNA
binding domain (PBD), which directs association of DNMT1 tothe replication foci, the targeting sequence (TS), required for
association with peri-centromeric heterochromatin and the
cystein-rich region (CxxC) (Fig. 1B) [31–37]. No binding was
observed with a deletion protein containing just the bromo ho-
mology domain 1 (BAH1), but a weak interaction was supported
when both BAH1 and BAH2 were present in the GST–DNMT1
mutant protein (Fig. 5E, aa 686–812 and aa 746–1110, re-
spectively). Residues located in the C-terminal catalytic domain
were shown to contribute to the binding interface (Fig. 5E, aa
1124–1620). This is not unexpected, as it has been proposed that
the DNMT1 activity depends on the presence of an intra-
molecular physical interaction between its N- and C-terminal
domains, suggesting that residues from these two regions come
in close association in the correctly folded DNMT1 protein
[36,37]. HESX1–DNMT1 interaction is mediated by the same
regions responsible for the interaction between DNMT1 and the
PcG protein EZH2, a histone methyltransferase associated with
transcriptional repression [38]. Overall, our data suggest that
rather than a specific sequence motif, the tertiary structures of
DNMT1 and HESX1 are essential for their interaction.
A GST pull-down assay was also performed on protein ex-
tracts obtained from untransfected ES cells, which express
Hesx1 at low levels. GST full-length HESX1 (aa 1–185) was
able to bind endogenous DNMT1, as indicated by the detection
of an immunoreactive band using a specific anti-DNMT1 anti-
body in Western blot analysis of GST–HESX1 (aa 1–185)
bound proteins (Fig. 5G). No binding was detected to GST,
Fig. 5. Mapping of the regions responsible for the interaction between HESX1 and DNMT1. (A) Schematic representations of HESX1 fragments expressed as GST
fusion proteins. (B) GST pull-down experiments. DNMT1 (aa 1–1620) (arrowhead) strongly interacts with GST–HESX1 (aa 1–185), whilst binding to GST–HESX1
(aa 1–107) is weak. (C) Representative Coomassie stain of the GST–HESX1 fusion proteins used in panel B. (D) Schematic representation of DNMT1 fragments
expressed as GST fusion proteins. (E) GST pull-down experiments. Strong interaction with HESX1 (aa 1–185) (arrowhead) is observed with DNMT1 fragments
containing the first 748 aa (aa 1–343, aa 350–609, aa 613–7480 and aa 653–730) and the catalytic domain (aa 1124–1620). No binding was detected with a DNMT1
fragment containing the BAH1 domain (aa 686–812). A DNMT1 fragment including BAH1 and BAH2 domains (aa 746–1110) exhibited weak binding. (F)
Representative Coomassie stain of the GST–DNMT1 fusion proteins used in panel B. As input, 1/10th of the total amount of 35S-Met-labelled protein was used in panels
B and E. (G) Approximately 1 mg of protein extracts obtained from untransfected ES cells was incubated with either an anti-DNMT1 antibody (IP: anti-DNMT1), GST
or GST–HESX1 (aa 1–185), and bound proteins analysed byWestern blot using an anti-DNMT1 antibody. Only GST–HESX1 (aa 1–185), but not GST, interacts with
endogenous DNMT1. Molecular weight markers are indicated on the left of each panel.
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firming previous results using in vitro translated DNMT1.
3.4. HESX1–DNMT1 interaction in mammalian cells
To confirm the interaction between HESX1 and DNMT1
further, co-immunoprecipitation of Flag–DNMT1 and HA–
HESX1 tagged proteins was performed on transfected cell lines.As shown in Fig. 6, Western blot analysis of the immunopre-
cipitates with an anti-HA antibody revealed that HESX1
interacts with DNMT1 in 293T cells. Moreover, immunopre-
cipitation with an anti-Flag antibody followed by Western blot
with an anti-HA antibody, also corroborated that HESX1 and
DNMT1 form complexes in these cells (Fig. 6). Similar results
were obtained in co-immunoprecipitation experiments per-
formed on transfected CHO cells, although protein levels were
Fig. 6. Co-immunoprecipitation of HESX1 and DNMT1 tagged proteins in 293Tcells. Cells were transfected with plasmids expressing full-length HA–HESX1 and/or
full-length Flag–DNMT1 (indicated by + or −) and immunoprecipitated with anti-flag and anti-HA antibodies. Immunoprecipitates were blotted and detected with
anti-HA or anti-Flag HRP-conjugated antibodies. Specific immunoreactive bands are indicated with arrowheads.
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unpublished data).
We also co-transfected 293T cells with plasmids expressing
DNMT1 deletion mutants. These experiments confirmed, as
previously described, that the N-terminal half and the C-terminal
catalytic domain of DNMT1 are involved in the interaction with
HESX1 (Fig. 7). No binding to HESX1 was detected with the
DNMT1 fragment (aa 1–158) and weak interaction was ob-
served with a longer peptide encompassing DNMT1 (aa 1–296),
which includes the PCNA binding motif (Fig. 7B, C). The
DNMT1 catalytic domain (aa 1124–1620) failed to interact with
HESX1, but expression levels of this fragment were very low in
transfected cells (Sajedi, E. and Martinez-Barbera, J.P.,
unpublished data).
However, DNMT1 deletion proteins containing the TS and
the CxxC domains and the catalytic domain (aa 158–1620 and
aa 296–1620) strongly interacted with HESX1 (Fig. 7E, F).
Overall, the co-immunoprecipitation experiments suggest that
the three-dimensional structure of DNMT1 is required for the
interaction.
Finally, we performed immunocytochemistry to determine
the localisation of HESX1 and DNMT1 on co-transfected CHO
cells. As shown in Fig. 8, both proteins are predominantly
nuclear and were found to co-localise (yellow in merged panels,
Fig. 8C, F).
3.5. The repressor activity of HESX1 is not enhanced upon
binding to DNMT1
We next examined whether the HESX1–DNMT1 interaction
might have an effect on the repressor activity of HESX1. This
possibility was investigated using a mammalian one-hybrid
system we have previously established in transfected CHO and
293T cells [10,11,17]. In this system, transfection of a construct
expressing the HESX1 protein as a fusion to the DNA binding
domain (DBD) of Gal4 (Gal4DBD–HESX1) leads to the repres-
sion of a constitutively active luciferase reporter (p-Gal4BS-
SV40 luciferase) in a dose-dependent manner (Fig. 9A. When
cells were co-transfected with a plasmid expressing DNMT1, therepressing activity of Gal4–HESX1 was not increased (Fig. 9B).
Similar results to those shown in Fig. 9B were obtained with a
range of concentrations of reporter and effector vectors. We also
performed luciferase assays using a reporter plasmid containing
six copies of the consensus binding site for the paired-like
family of homeodomain proteins, which includes HESX1
(p-P3-SV40 luciferase) and effector plasmids expressing the
full-length HESX1 protein, rather than a fusion protein to
Gal4DBD. In these conditions, addition of DNMT1 also failed
to enhance the repressor activity of HESX1 on the P3 reporter
vector in a wide range of concentrations (Sajedi, E. and
Martinez-Barbera, J.P., unpublished data). Together, these
results suggest that binding of DNMT1 to HESX1 cannot in-
crease the repressor activity of HESX1 in transient luciferase
assays in transfected cells.
4. Discussion
4.1. Identification of HESX1-interacting proteins
Hesx1 is a developmental transcriptional repressor essential
for normal forebrain and pituitary formation in mouse and
human [6,7]. A total of 13 HESX1 mutations have been iden-
tified so far in association with SOD and/or hypopituitarism:
eight of them are point mutations resulting in a single aa change
(Q6H, I26T, E149K, R160C, S170L, T181A,Q117P, K176T)
[8–12]; one results from the deletion of a guanine in codon 175
(1684delG) causing a frameshift mutation and the generation of
a novel C-terminus [13]; a further mutation involves the inser-
tion of an Alu element in the homeodomain leading to skipping
of exon 3 (AluIII) [14]; two more result from the insertion or
deletion of two nucleotides (306/307insAG and 449/450delAC,
respectively) causing a frameshift mutation and the premature
termination of translation due to the introduction of a stop codon
[15,16]; and a final one is the consequence of a T to C transition
at position +2 of exon 2, which mutates the invariant dinu-
cleotide of the splice donor site of intron 2, yielding a HESX1
truncated protein lacking the homeodomain [16]. The pene-
trance and severity of the phenotype are highly variable in
Fig. 7. (A) Schematic representation of full-length DNMT1 (aa 1–1620) and fragments used in these experiments. Cells were transfected with full-length HA–HESX1
and/or several Flag–DNMT1 deletion proteins as indicated (+ or −) and immunoprecipitated with anti-Flag or anti-HA antibodies. The presence of HESX1–DNMT1
complexes was analysed by Western blotting the anti-Flag immunoprecipitates with an HRP-conjugated anti-HA antibody. Specific immunoreactive bands are
indicated with arrowheads. Fragments containing part of the N-terminus and the catalytic domain of DNMT1 (aa 158–1620 and aa 296–1620) strongly interact with
HA–HESX1. Immunoprecipitation with anti-HA antibody was used to verify the presence of HA–HESX1 in the lysates.
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ferences in severity of the phenotypes might be caused by
specific perturbations in the protein–protein interactions be-
tween particular HESX1 mutated proteins and specific partners.
Moreover, the possibility exists for a more direct contribution of
HESX1-interacting proteins in human disease, i.e., mutations in
HESX1 partners might also lead to congenital hypopituitarism
and SOD. These experiments are currently being performed and
will be published elsewhere.
To gain insights into the molecular function of HESX1 in
normal development and disease, we have carried out a yeast
two-hybrid screen and identified five HESX1 interactors. Atleast three of these are associated with transcriptional repression,
whilst the other two are of unknown function. DNMT1 has been
shown to play essential roles in several processes including gene
silencing. SAFB1 is a transcriptional repressor, which is also
involved in chromatin remodelling [39]. SRFBP1 interacts with
SRF (serum response factor) to modulate SRF activating
properties on a variety of promoters [29].
The expression analysis suggests that all five interactors are
co-expressed with Hesx1 within the anterior forebrain by in situ
hybridisation and RT-PCR. Moreover, isolation of pure pop-
ulations of Hesx1-expressing cells from the anterior forebrain
and subsequent gene expression profiling has confirmed that all
Fig. 8. Localisation of HESX1 and DNMT1 in CHO cells. Immunofluorescence was performed on cells transfected with HA–HESX1 and Flag–DNMT1 tagged
proteins. (A, D) HA–HESX1 staining (green) is mostly nuclear, but sporadic cells also show cytoplasmic staining. (B, E) Flag–DNMT1 staining (red) is
predominantly nuclear. (C) Merged photographs of panels A and B. (F) Merged photographs of panels D and E. Co-localisation of HA–HESX1 and Flag–DNMT1is
observed in the nucleus (yellow staining in panels C and F). Scale bar: 100 μm.
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sing cells (Andoniadou, C.L. and Martinez-Barbera, J.P.,
unpublished data). Dnmt1, Safb1 and Lonp2 were highly
expressed followed by Zfp592 and Srfbp1, which were weakly
expressed. This is consistent with the data obtained from the RT-
PCR and in situ hybridisation analysis described here.
Remarkably, we have found that the expression pattern of
Dnmt1 and Safb1 in the developing Rathke's pouch is very
similar to that of Hesx1. Hesx1 expression is high in the dorsal
region of Rathke's pouch at 12.5 dpc, where progenitor cells are
actively dividing, and low in the ventral part, where cell
differentiation is taking place [17]. This suggests thatDnmt1 and
Safb1 may be required for normal pituitary formation in mouse.
In fact, Safb1−/− mutant mice die perinatally and surviving
individuals exhibit dwarfism due to low levels of insulin-like
growth factor 1 [40], a phenotype compatible with hypopituita-
rism, i.e., isolated growth hormone deficiency. Dnmt1−/− mice
die early in gestation, but knock-down approaches have revealed
that reduction ofDnmt1 leads to microcephaly (small heads) and
defects in terminal differentiation in some organs [31,41]. The
pituitary gland was not analysed in these studies.
Together, these findings suggest that HESX1 interacts with
several proteins involved in gene repression to execute its func-
tion during the development of the forebrain and the pituitary
gland.4.2. DNMT1–HESX1 interaction: is there a link between HESX1
and DNA methylation?
In this manuscript, we present evidence supporting the
hypothesis that there is a direct interaction between HESX1 and
DNMT1, which has been verified (1) in yeast, by a two-hybrid
system; (2) in vitro, by GST pull-down assays; and (3) in
mammalian cells, by co-immunoprecipitation and co-localisa-
tion experiments; (4) by expression analysis in the mouse
embryo using RT-PCR and in situ hybridisation. Mapping of
the interacting regions suggests that the tertiary structure of
both proteins, rather than specific motifs or domains, is
required for their interaction. Results obtained from a
mammalian one-hybrid system suggest that recruitment of
DNMT1 by HESX1 cannot enhance HESX1 activity as a
transcriptional repressor. This is in contrast with previous
results from our group and from others that have shown that co-
transfection of TLE1 or N-CoR, another two known HESX1-
interacting proteins, can increase the repressor activity of
HESX1 in transfected cells using the same one-hybrid system
[10,11,17]. A possibility to explain this discrepancy may be
that the interaction of HESX1 with DNMT1 influences the
activity of HESX1 in a way that cannot be detected in a one-
hybrid system. Alternatively, the functional relevance of the
interaction might not be to increase HESX1-repressor activity,
Fig. 9. HESX1 repressor activity is not enhanced by DNMT1 in a mammalian
one-hybrid system. (A) The basal activation of a luciferase reporter vector
containing the SV40 promoter and Gal4 DNA binding sites (p-Gal4BS-SV40-
Luc) can be repressed by expression of Gal4 DNA binding domain (DBD)–
HESX1 fusion protein from the p-Gal4DBD–Hesx1 effector plasmid in a dose-
dependent manner. (B) Co-transfection of DNMT1 cannot increase the repressor
activity of the Gal4DBD–Hesx1 fusion protein.
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expressing cells.
Analysis of the Hesx1-deficient embryos has shown that the
loss of Hesx1 leads to a posterior transformation of the anterior
forebrain [19]. Anterior forebrain structures, such as the eyes
and the telencephalic vesicles (which will later form the cerebral
hemispheres), are reduced in size, in favour of more posterior
structures. At the molecular level, this change of cell fate can be
visualised by the ectopic expression of posteriorising genes in
the anterior neural ectoderm. The de-repression of posterior
marker expression in the anterior forebrain brings about the
posterior transformation. This phenotype is consistent with the
idea that HESX1 functions as a repressor within the anterior
forebrain. Indeed, there is biochemical evidence demonstrating
a physical interaction between HESX1 and the co-repressors
TLE1 and N-CoR [10,17]. Through these interactions, HESX1
associates in multimeric protein complexes with other co-
repressors, such as mSIN3, HDAC1/2 and members of the
mammalian SWI/SNF complex, to modify histones, alter
chromatin structure and cause repression [17].
Compelling evidence indicates that DNMT1 plays an essen-
tial role in the maintenance of transcriptionally repressed chro-
matin. Methylation of CpG sites is generally inversely correlatedwith transcriptional activity [20–22]. DNMT1 activity is con-
trolled by its interaction with several proteins, including pRb,
DMAP1, HDAC1/2, MeCP2, SUV39H1, HP1beta, p23, p53,
EZH2 and the nucleolar chromatin remodelling complex Tip5/
Snf2h (Fig. 1) [38,42–50]. These interactions mediate tran-
scriptional repression through independent mechanisms, such as
histone deacetylation and methylation, disruption of transcrip-
tional activation complexes and chromatin remodelling. Based
on the physical interaction between HESX1 and DNMT1 shown
in the present study, we postulate that HESX1 may induce
permanent gene silencing by an additional mechanism of action,
namely the specific methylation of CpG residues of HESX1
target genes.
One intriguing characteristic of Hesx1-deficient embryos is
the variable expressivity of the severity of the forebrain and
pituitary defects [6,7,19]. This variability was initially thought to
be the consequence of a mixed genetic background in theHesx1-
deficient embryos. However, Hesx1 heterozygous mice have
been backcrossed with C57BL6/J for more than 20 generations,
ensuring a pure genetic background, but variable expressivity of
the phenotype still persists [19]. This is not particular to mouse,
as similar variability is observed in human patients carrying
mutations in HESX1, and often between siblings [8–16]. The
interaction with DNMT1 can explain the underlying cause of
this variable expressivity in the phenotype, as epigenetic modi-
fications have been proven to cause differences in gene expres-
sion in identical genotypes [51]. DNMT1-deficient embryos and
cells show a generalised genomic hypomethylation and a reduc-
tion in gene repression [31,52,53]. It is tempting to speculate that
lack of HESX1 in mutant embryos may cause demethylation of
specific HESX1 target genes, as has been shown for other DNA
binding proteins [38]. The uneven reduction of CpGmethylation
between mutant embryos of the same genetic background could
lead to erratic de-repression and ectopic activation of caudalising
genes within the forebrain, and therefore to a variable pheno-
type. The demonstration of this hypothesis is currently hampered
by the lack of knowledge about direct HESX1 targets in vivo.
The identification of genes directly regulated by HESX1 will
allow us to characterise their methylation patterns in wild-type
and Hesx1-deficient embryos in vivo, and to correlate these
molecular data with the severity of the phenotype of Hesx1−/−
mutants.
In summary, five HESX1-interacting proteins have been
identified in a yeast two-hybrid screen, including DNMT1.
The present investigation represents the first step towards the
elucidation of the functional consequences of these interac-
tions during development. Future studies will reveal whether
the identified HESX1 partners may be involved in the aetio-
logy and pathogenesis of human syndromes, such as SOD and
hypopituitarism.
Acknowledgments
We thank A. Stoker, N. Greene and A. Copp for critical
reading of the manuscript. We are grateful to P. Scambler and P.
Ataliotis for helping with the yeast-two hybrid screen, and to
Albert Jeltsch for kindly providing the original cDNA clone of
142 E. Sajedi et al. / Biochimica et Biophysica Acta 1783 (2008) 131–143DNMT1 used in the GST fusions. We also thank S. Oesterreich
for providing the Safb1 clone. This work was supported by
grants 068630 and 078432 from The Wellcome Trust, and by
grant 1ZTG from UCL Central Funds. E. Sajedi is the recipient
of a PhD studentship funded by the Child Health Research
Appeal Trust.
References
[1] E. Hermesz, S. Mackem, K.A. Mahon, Rpx: a novel anterior-restricted
homeobox gene progressively activated in the prechordal plate, anterior
neural plate and Rathke's pouch of the mouse embryo, Development 122
(1996) 41–52.
[2] P. Thomas, R. Beddington, Anterior primitive endoderm may be respon-
sible for patterning the anterior neural plate in the mouse embryo, Curr.
Biol. 6 (1996) 1487–1496.
[3] E. Hermesz, L. Williams-Simons, K. Mahon, A novel inducible element,
activated by contact with Rathke's pouch, is present in the regulatory
region of the Rpx/Hesx1 homeobox gene, Dev. Biol. 260 (2003) 68–78.
[4] H. Knoetgen, C. Viebahn, M. Kessel, Head induction in the chick by
primitive endoderm of mammalian, but not avian origin, Development 126
(1999) 815–825.
[5] O.V. Kazanskaya, E.A. Severtzova, K.A. Barth, G.V. Ermakova, S.A.
Lukyanov, A.Q. Benyumov, M. Pannese, E. Boncinelli, S.W. Wilson, A.G.
Zaraisky, Anf: a novel class of vertebrate homeobox genes expressed at the
anterior end of the main embryonic axis, Gene 200 (1997) 25–34.
[6] M.H. Dattani, J.P. Martinez Barbera, P.Q. Thomas, J.M. Brickman, R.
Gupta, I.L. Martensson, H. Toresson, M. Fox, J.K.H. Wales, P.C.
Hindmarsh, S. Krauss, R.S.P. Beddington, I.C.A.F. Robinson, Mutations
in the homeobox gene Hesx1/HESX1 associated with septo-optic dysplasia
in human and mouse, Nat. Genet. 19 (1998) 125–133.
[7] J.P. Martinez-Barbera, T.A. Rodriguez, R.S. Beddington, The homeobox
geneHesx1 is required in the anterior neural ectoderm for normal forebrain
formation, Dev. Biol. 223 (2000) 422–430.
[8] M.T. Dattani, Novel insights into the aetiology and pathogenesis of
hypopituitarism, Hormone Research 62 (2004) 1–13.
[9] P.Q. Thomas, M.T. Dattani, J.M. Brickman, D. McNay, G. Warne, M.
Zacharin, F. Cameron, J. Hurst, K. Woods, D. Dunger, R. Stanhope, S.
Forrest, I.C.A.F. Robinson, R.S.P. Beddington, Heterozygous HESX1
mutations associated with isolated congenital pituitary hypoplasia and
septo-optic dysplasia, Hum. Mol. Genet. 10 (2001) 39–45.
[10] L.R. Carvalho, K.S. Woods, B.B. Mendonca, N. Marcal, A.L. Zamparini, S.
Stifani, J.M. Brickman, I.J. Arnhold, M.T. Dattani, A homozygous mutation
in HESX1 is associated with evolving hypopituitarism due to impaired
repressor-corepressor interaction, J. Clin. Invest. 112 (2003) 1192–1201.
[11] J.M. Brickman, M. Clements, R. Tyrell, D. McNay, K. Woods, J. Warner,
A. Stewart, R.S.P. Beddington, M. Dattani, Molecular effects of novel
mutations in Hesx1/HESX1 associated with human pituitary disorders,
Development 128 (2001) 5189–5199.
[12] R. Coya, A. Vela, G. Perez de Nanclares, I. Rica, L. Castaño, M.A.
Busturia, P. Martul, Panhypopituitarism: genetic versus acquired factors,
J. Pediatr. Endocrinol. Metab. 20 (2007) 27–36.
[13] R.N. Cohen, L.E. Cohen, D. Botero, C. Yu, A. Sagar, M. Jurkiewicz, S.
Radovick, Enhanced repression by HESX1 as a cause of hypopituitarism and
septooptic dysplasia, J. Clin. Endocrinol. Metab. 88 (2003) 4832–4839.
[14] M.L. Sobrier, I. Netchine, C. Heinrichs, N. Thibaud, M.P. Vie-Luton, G.V.
Vliet, S. Amselem, Alu-element insertion in the homeodomain of Hesx1
and aplasia of the anterior pituitary, Human Mutat. 25 (2005) 503.
[15] T. Tajima, T. Hattori, T. Nakajima, K. Okuhara, K. Sato, S. Abe, J. Nakae,
K. Fujieda, Sporadic heterozygous frameshift mutation of HESX1 causing
pituitary and optic nerve hypoplasia and combined pituitary hormone
deficiency in a Japanese patient, J. Clin. Endocrinol. Metab. 88 (2003)
45–50.
[16] M.L. Sobrier, M. Maghnie, M.P. Vie-Luton, A. Secco, N. diIorgi, R.
Lorini, S. Amselem, Novel HESX1 mutations associated with life-
threatening neonatal phenotype, pituitary aplasia, but normally locatedposterior pituitary and no optic nerve abnormalities, J. Clin. Endocrinol.
Metab. 91 (2006) 4528–4536.
[17] J.S. Dasen, J.P. Martinez Barbera, T.S. Hernan, S. O'Connel, L. Olson, B.
Ju, J. Tollkuhn, S.H. Buek, D.W. Rose, M.G. Rosenfeld, Temporal
switching of a paired-like homeodomain repressor/TLE corepressor
complex for a related activator mediates pituitary organogenesis, Genes
Dev. 15 (2001) 3193–3207.
[18] G.V. Ermakova, E.M. Alexandrova, O.V. Kazanskaya, O.L. Vasiliev, M.W.
Smith, A.G. Zaraisky, The homeobox gene, Xanf1, can control both neural
differentiation and patterning in the presumptive anterior neurectoderm of
the Xenopus laevis embryo, Development 126 (1999) 4513–4523.
[19] C.L. Andoniadou, M. Signore, E. Sajedi, C. Gaston-Massuet, K. Kelber-
man, A.J. Burns, N. Itasaki, M. Dattani, J.P. Martinez-Barbera, Lack of the
murine homeobox gene Hesx1 leads to a posterior transformation of the
anterior forebrain, Development 134 (2007) 1499–1508.
[20] A. Hermann, H. Gowher, A. Jeltsch, Biochemistry and biology of
mammalian DNA methyltransferases, Cell. Mol. Life Sci. 61 (2004)
2571–2587.
[21] F. Spada, U. Rothbauer, K. Zolghadr, L. Schermelleh, H. Leonhardt,
Regulation of DNA methyltransferase 1, Adv. Enzyme Regul. 46 (2006)
224–234.
[22] T.H. Bestor, The DNA methyltransferases of mammals, Hum. Mol. Genet.
9 (2000) 2395–2402.
[23] P. James, J. Halladay, E.A. Craig, Genomic libraries and a host strain
designed for highly efficient two-hybrid selection in yeast, Genetics 144
(1996) 1425–1436.
[24] E.S. Casey, M. Tada, L. Fairclough, C.C. Wyllie, J. Heasman, J.C. Smith,
Bix4 is activated directly by VegT and mediates endoderm formation in
Xenopus development, Development 126 (1999) 4193–4200.
[25] A.P. Coutinho, C. Borday, J. Gilthorpe, S. Jungbluth, J. Champagnat, A.
Lumsden, G. Fortin, Induction of a parafacial rhythm generator by
rhombomere 3 in the chick embryo, J. Neurosci. 24 (2004) 9383–9390.
[26] S.M. Hollenberg, R. Sternglanz, P.F. Cheng, H. Weintraub, Identification
of a new family of tissue-specific basic helix–loop–helix proteins with a
two-hybrid system, Mol. Cell. Biol. 15 (1995) 3813–3822.
[27] E.J. Robertson, Teratocarcinomas and Embryonic Stem Cells a Practical
Approach, IRL press, Oxford, 1987.
[28] S.M. Townson, K. Kang, A.V. Lee, S. Oesterreich, Structure–function
analysis of the estrogen receptor alpha corepressor scaffold attachment
factor-B1, J. Biol. Chem. 279 (2004) 26074–26081.
[29] X. Zhang, G. Azhar, Y. Zhing, J.Y. Wei, Identification of a novel serum
response factor cofactor in cardiac gene regulation, J. Biol. Chem. 279
(2004) 55626–55632.
[30] M. Nakamura, A.P. Runko, C.G. Sagerstrom, A novel subfamily of zinc
finger genes involved in embryonic development, J. Cell. Biochem. 93
(2004) 887–895.
[31] I. Stancheva, R.R. Meehan, Transient depleteion of xDnmt1 leads to
premature gene activation in Xenopus embryos, Genes Dev. 14 (2000)
313–327.
[32] L. Jackson-Grusby, C. Beard, R. Possemato, M. Tudor, D. Fambrough, G.
Csankovszki, J. Dausman, P. Lee, C. Wilson, E. Lander, R. Jaenisch, Loss
of genomix methylation causes p53-dependent apoptosis and epigenetic
deregulation, Nat. Genet. 27 (2001) 9–10.
[33] L. Lande-Diner, J. Zhang, I. Ben-Porath, N. Amariglio, I. Keshet, M.
Hecht, V. Azuara, A.G. Fisher, G. Rechavi, H. Cedar, Role of DNA
methylation in stable gene expression, J. Biol. Chem. 282 (2007)
12194–12200.
[34] L.S.H. Chuang, H.I. Ian, T.W. Koh, H.H. Ng, G. Xu, B.F.L. Li, Human
DNA-(cytosine-5) methyltransferase-PCNA complex as a target for
p21WAF1, Science 277 (1997) 1996–2000.
[35] H. Leonhardt, A.W. Page, H.U. Weier, T.H. Bestor, A targeting sequence
directs DNA methyltransferase to sites of DNA replication in mammalian
nuclei, Cell 71 (1992) 865–873.
[36] M. Fatemi, A. Hermann, S. Pradhan, A. Jeltsch, The activity of the murine
DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic
domain with the N-terminal part of the enzyme leading to an allosteric
activation of the enzyme after binding to methylated DNA, J. Mol. Biol.
309 (2001) 1189–1199.
143E. Sajedi et al. / Biochimica et Biophysica Acta 1783 (2008) 131–143[37] J.B. Margot, A.E. Ehrenhofer-Murray, H. Leonhardt, Interactions within
the mammalian DNA methyltransferase family, BMC Mol. Biol. 4
(2003) 7.
[38] E. Vire, C. Brenner, R. Deplus, L. Blanchon, M. Fraga, C. Didelot, L.
Morey, A. van Eynde, D. Bernard, J.M. Vanderwinden, M. Bollen, M.
Esteller, L. Di Croce, Y. de Launoit, F. Fuks, The polycomb group protein
EZH2 directly controls DNA methylation, Nature 439 (2006) 871–874.
[39] S. Oesterreich, Scaffold attachment factors SAFB1 and SAFB2: innocent
bystanders or critical players in breats tumorigenesis, J. Cell. Biochem. 90
(2003) 653–661.
[40] M. Ivanova, K.M. Dobrzycka, S. Jiang, K. Michaelis, R. Meyer, K. Kang,
B. Adkins, O.A. Barski, S. Zubairy, J. Divisova, A.V. Lee, S. Oesterreich,
Scaffold attachment factor B1 functions in development, growth, and
reproduction, Mol. Cell. Biol. 25 (2005) 2995–3006.
[41] K. Rai, L.D. Nadauld, S. Chidester, E.J.Manos, S.R. James, A.R.Karpf. B.R.
Cairns, D.A. Jones, Zebra fish Dnmt1 and Suv39h1 regulate organ-specific
terminal differentiation during development, Mol. Cell. Biol. 26 (2006)
7077–7085.
[42] K.D. Robertson, S. Ait-Si-Ali, T. Yokochi, P.A. Wade, P.L. Jones, A.P.
Wolffe, DNMT1 forms a complex with Rb, E2F1 and HDAC1 and re-
presses transcription from E2F-responsive promoters, Nat. Genet. 25
(2000) 338–342.
[43] A.K. Robertson, T.M. Geiman, U.T. Sankpal, G.L. Hager, K.D. Robertson,
Effects of chromatin structure on the enzymatic and DNA binding
functions of DNA methyltransferases DNMT1 and DNMT3a in vitro,
Biochem. Biophys. Res. Commun. 322 (2004) 110–118.
[44] R. Santoro, J. Li, I. Grummt, The nucleolar remodelling complex N-CoR
mediates heterochromatin formation and silencing of ribosomal gene
transcription, Nat. Genet 32 (2002) 393–396.[45] M.R Rountree, K.E. Bachman, S.B. Baylin, DNMT1 binds HDAC2 and a
new co-repressor, DMAP1, to form a complex at replication foci, Nat.
Genet. 25 (2000) 269–277.
[46] X. Zhang, G.L. Verdine, Mammalian DNA cytosine-5 methyltransferase
interacts with p23 protein, FEBS Lett. 378 (1996) 393–405.
[47] P.O. esteve, H.G. Chin, S. Pradhan, Human maintenance DNA (cytosine-
5)-methyltransferase and p53 modulate expression of p53-repressed
promoters, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1000–1005.
[48] F. Fuks, W.A. Burgers, A. Brehm, L. Hughes-Davies, T. Kouzarides, DNA
methyltransferase Dnmt1 associates with histone deacetylase activity, Nat.
Genet. 24 (2000) 88–91.
[49] F. Fuks, P.J. Hurd, R. Deplus, T. kouzarides, The DNA methyltransferases
associate with HP1 and the SUV39H1 histone methyltransferase, Nucl.
Acids Res. 31 (2003) 2305–2312.
[50] H. Kimura, K. Shiota, Methyl-CpG-binding protein, MeCP2, is a target
molecule for maintenance DNA methyltransferase, Dnmt1, J. Biol. Chem.
278 (2003) 4806–4812.
[51] M.F. Fraga, E. Ballestar, M.F. Paz, S. Ropero, F. Setien, M.L. Ballestar, D.
Heine-Suner, J.C. Cigudosa, M. Urioste, J. Benitez, M. Boix-Chornet, A.
Sanchez-Aguilera, C. Ling, E. Carlsson, P. Poulsen, A. Vaag, Z. Stephan,
T.D. Spector, Y.Z. Wu, C. Plass, M. Esteller, Epigenetic differences arise
during the lifetime of monozygotic twins, Proc. Natl. Acad. Sci. U. S. A.
102 (2005) 10604–10609.
[52] E. Li, T.H. Bestor, R. Jaenisch, Targeted mutation of the DNA
methyltransferase gene results in embryonic lethality, Cell 69 (1992)
915–926.
[53] M.F. Chan, R. vanAmerongen, T. Nijjar, E. Cuppen, P.A. Jones, P.W. Laird,
Reduced rates of gene loss, gene silencing and gene mutation in DNMT1
deficient embryonic stem cells, Mol. Cell. Biol. 21 (2001) 7587–7600.
